Lungcast

Pulmonary vascular disease expert Dr. Parth Rali at Temple Lung Center helps break down what is known about massive and submassive pulmonary emboli (PE), namely blood clots. This episode provides a comprehensive overview of PE, from the complications of diagnosis to the evolution of therapeutic modalities.

Episode highlights
0:16 Intro
2:34 Defining pulmonary embolism classifications
8:18 The Pulmonary Embolism Severity Index
15:47 The role of D-dimer in diagnosis
17:08 Anticoagulation strategies
22:26 The Pulmonary Embolism Multidisciplinary Response Team
25:38 Long-term outlooks for acute PE
31:38 When to stop anticoagulation
35:27 The future of PE diagnosis and treatment
38:50 Outro

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

In this must-listen episode, Dr. Julia Moore Vogel at Scripps Research takes center stage to confer the still-emerging and always-evolving space of long COVID. As patient numbers continue to rise at an alarming rate, she makes a strong case about the critical need to better define the disease, mitigate its impact and, ultimately, break the taboo.

Episode highlights
0:15 Introduction
1:27 Moore Vogel’s background in Long Covid
4:30 Lacking terminology in Long Covid
6:20 Quantifying Long Covid disease
8:38 The mechanism of action: what we know
10:27 Pediatric Long Covid
16:00 Similarities to post-viral syndromes
16:58 Key diagnostic tools
18:37 The current Long Covid treatment landscape
20:57 Influence of SARS-CoV-2 variants and vaccines
22:02 Considering social determinants of health
23:35 Needs for professional and public education
27:00 Final thoughts
28:28 Outro

Want more Lungcast? Visit us at HCPLive.com or Lung.org.

For this episode focusing on the role of medical oncology, we are joined by Dr. Carolyn Presley, thoracic oncologist and associate professor with tenure at Ohio State University. As a geriatric expert, she provides a poignant point-of-view on the need for a multidisciplinary approach to patient care, as well as advances in treatment that include targeted therapies.

Amid mass poor air quality exposure due to ongoing Canadian wildfires, Lungcast host and ALA Chief Medical Officer Albert Rizzo, MD, explains air quality index (AQI), signs and symptoms of acute and long-term poor air exposure, high-risk patient populations, and the concerning future of particle pollution exposure.

Want more Lungcast? Visit us at HCPLive.com or Lung.org.

Episode Highlights
0:15 Intro
1:23 What is the Air Quality Index?
3:14 Risk factors of poor air quality
4:30 Acute signs and symptoms
6:42 Recommendations for patients with pre-existing conditions
8:09 How long will this last?
10:28 When to resume livelihood
11:12 The long-term impact of air pollution exposure
14:02 Outro

Anne Dixon, MD, Director of Pulmonary and Critical Care Medicine at University of Vermont Medical Center and the first repeat guest in the history of Lungcast, rejoins American Lung Association Chief Medical Officer Albert Rizzo, MD, on the floor at the American Thoracic Society (ATS) 2023 International Conference in Washington, DC, to discuss headline news from the annual meeting and her ongoing work in clinical airway research.

Want more Lungcast? Visit us at HCPLive.com or Lung.org.

Episode Highlights
0:15 Intro
1:00 Obesity burdens in asthma
3:22 Weight loss intervention data at ATS 2023
4:53 ALA grants program
7:00 Airways Clinical Research Network
10:52 Seeking research collaborators
12:46 Merging clinicians, patients and industry in innovative research
13:54 Outro

Just in time for May’s Asthma and Allergy Awareness Month, allergist and immunologist Dr. Payel Gupta of LifeMD.com headlines a conversation about the clinical presentation of asthma and its role in the atopic march. She also details various phenotypes, endotypes and other molecular mechanisms of asthma that can be applied to help guide disease management and treatment decisions.

Episode highlights
0:15 Intro
1:16 Introducing Payel Gupta, MD
2:31 Classifications of asthma
5:35 What is the atopic march?
8:46 The bridge from allergy testing to immunotherapy
12:00 How to initially diagnose asthma
16:02 When to add secondary therapies
18:11 Biologics for uncontrolled asthma
23:20 Real-world use of the SMART therapy guidance
25:40 Assuring asthma treatment adherence
28:35 Addressing asthma care disparities
32:26 The future of asthma research
33:58 Outro

Check out other allergy and/or asthma episodes of Lungcast:

For our 30th episode of Lungcast™, pulmonologist Dr. Ravi Kalhan of Northwestern Medicine joins for a core-level discussion on the modeling of respiratory health and pulmonary mechanisms. 

In addition to sharing how a novel machine learning method may one day soon predict lung disease susceptibility, Dr. Kalhan describes the science behind the American Lung Association Lung Health Cohort Research Study.

David Tom Cooke, MD, Founding Chief of the Division of General Thoracic Surgery at UC Davis, joins the first episode of 2023 to discuss his colleague’s specific role in lung cancer screening and intervention, advances to minimally invasive, robotic and bronchoscopic techniques, and evolving strategies in individualized patient care.

Episode Highlights
0:14 Intro
1:52 Introducing David T. Cooke, MD
3:23 The role of thoracic surgeons in improving lung cancer screening rates
6:22 Shared decision making in thoracic surgery
8:16 Lobar, wedge resection or segmentectomy? Plus, robotic techniques?
12:22 PET/CT scans in the staging process
13:52 The surgeon approach to stage IV lung cancer
16:02 Patient follow-up—improved mortality and longer life expectancy
18:50 Prioritizing surgery and neoadjuvant therapy regimens
20:48 Thoracic surgeon role in palliative care
22:57 What’s on the horizon in the field: robotic surgery
24:17 Outro

Check out other lung cancer episodes of Lungcast:

Innovations in Interventional Pulmonology with Dr. Carla Lamb 

Will your New Year’s resolution kick off the journey to quit smoking? In our final Lungcast™ interview of 2022, Bob Levey, former Washington Post columnist and founder of the Super Stoppers Club, and the Lung Association’s national senior director of tobacco programs, Jennifer Folkenroth, come together to review the intricacies of smoking cessation. The lively and informative discussion outlines the path to a smoke-free life, which is often riddled with hurdles and stressors.

0:16 Ernst Wynder, Evarts Graham and the discovery of smoking - lung cancer risk
1:52 Introducing Jennifer Folkenroth and Bob Levey
4:46 Bob Levey and the Super Stoppers Club
11:25 The clinical effect of group cessation
14:00 Why is it hard to quit smoking?
17:45 The value of cessation support systems and social groups
20:03 Navigating patient concerns around cessation treatments
21:54 Combating stigma and social trends
26:35 Resources for aspiring quitters
31:26 Outro

Among many unintended and unexpected effects of sheltering in place during the COVID-19 pandemic is the substantial increase in exposures to indoor allergens and pollutants.

Here, Dr. Edward Brooks at University of Texas at San Antonio and Dr. Charlene McEvoy at University of Minnesota bring a shared expertise on air quality health and research to discuss the resulting health ramifications.

It is an enlightening conversation about the patient populations who are most impacted, plus what can be done to help mitigate the consequences.

Episode highlights
0:16 The history of indoor air environments
2:50 Introducing Edward G. Brooks, MD, and Charlene McEvoy, MD
4:39 The factors of poor indoor air quality
6:25 Ways to improve indoor air quality
8:59 The underlying pathophysiology of pollutants
13:02 Benzene recalls
14:18 High-risk behaviors and disease risks
17:14 Recommendations for exposed patients
21:02 Radon as a lung cancer risk
22:35 Final thoughts
25:42 Outro


For additional news and insights, visit us at HCPLive.com and Lung.org.